University of Sao Paulo
Metformin therapy benefits women with PCOS
Published in Women's Health Law Weekly, January 2nd, 2005
L.F. Santana and colleagues, University of Sao Paulo, Brazil, conducted "a longitudinal prospective study ... in 21 women with polycystic ovary syndrome (PCOS), aged 27.20 ± 5.02 years and treated with metformin (1500 mg/day) for 8 weeks."
"The patients were assessed for spontaneous menstruation, weight, body mass index (BMI), waist circumference, waist/hip ratio (WHR), glucose and insulin concentrations under fasting conditions and after a 75-g glucose tolerance test, lipid profile, testosterone, androstenedione, dehydroepiandrosterone sulfate,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Ascend Therapeutics
4-OHT gel reduces cyclic breast pain among premenopausal women, study shows - AstraZeneca
ATAC trial data reported comparing anastrozole to tamoxifen - Legal Issues
Women switched at birth settle lawsuits - Northwestern University
Healthcare costs higher for adults who were overweight or obese when younger - Obihiro Univ. of Agriculture & Veterinary Medicine
B. abortus Znu locus required for survival and virulence in mice - Playtex Moonwalk
2005 Playtex Moonwalk to raise money to fight breast cancer opens in London - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
